IRD Competitors & Alternatives
Compare Opus Genetics, Inc. with similar stocks in the same industry
Biotechnology
IRD
Main Stock$3.98
Tradestie Score
39
Market Cap
$107.83M
Revenue Growth
-0.6%
Analyst Upside
+250.3%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$5.60
|
$422.50M | - | 42 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$12.23
|
$407.71M | - | 53 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.47
|
$386.68M | - | 44 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.11
|
$382.04M | - | 34 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.38
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$9.53
|
$357.51M | - | 31 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$8.79
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$10.28
|
$354.45M | - | 46 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$43.01
|
$353.70M | - | 35 | Compare |
More IRD Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry